Budget Impact Analysis of the Fentanyl Buccal Tablet for Treatment of Breakthrough Cancer Pain

ClinicoEconomics and Outcomes Research - New Zealand
doi 10.2147/ceor.s52273
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Cost-Effectiveness Analysis of Oral Fentanyl Formulations for Breakthrough Cancer Pain Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Intranasal Fentanyl for Breakthrough Pain Control

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2012English

Role of Intranasal Fentanyl in Breakthrough Pain Management in Cancer Patients

Cancer Management and Research
Oncology
2010English

A New Fast-Acting Sublingual Fentanyl (Recivit®) for Treating Breakthrough Cancer Pain

European Oncology and Haematology
OncologyHematology
2014English

Evidence-Based Treatment of Cancer-Related Breakthrough Pain With Opioids

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2013English

Canadian Recommendations for the Management of Breakthrough Cancer Pain

Current Oncology
Oncology
2016English

Budget Impact Analysis of Low-Dose Methoxyflurane for the Treatment of Moderate-To-Severe Trauma Pain in Sweden

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Budget Impact Analysis of Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer From a u.s. Payer Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Budget Impact Analysis of Paliperidone Palmitate 3-Monthly for the Treatment of Schizophrenia in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy